Index
RUT
Market Cap
318.33M
Enterprise Value
475.82M
Income
-61.72M
Sales
833.19M
Book/sh
10.54
Cash/sh
2.56
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
1605
IPO
Apr 24, 1992
P/E
-
Forward P/E
-
PEG
-
P/S
0.38
P/B
0.74
P/C
3.05
P/FCF
-
EV/EBITDA
28.66
EV/Sales
0.57
Quick Ratio
1.67
Current Ratio
2.84
Debt/Eq
0.61
LT Debt/Eq
0.60
Option/Short
Yes / Yes
EPS (ttm)
-1.53
EPS next Y
-0.94
EPS next Q
0.00
EPS this Y
49.57%
EPS next Y
19.57%
EPS next 5Y
35.00%
EPS past 3/5Y
-33.21% -
Sales past 3/5Y
21.30% 15.13%
EPS Y/Y TTM
51.77%
Sales Y/Y TTM
2.99%
EPS Q/Q
-8.33%
Sales Q/Q
3.85%
Insider Own
1.21%
Insider Trans
-1.09%
Inst Own
95.13%
Inst Trans
2.74%
ROA
-7.22%
ROE
-13.91%
ROIC
-8.97%
Gross Margin
69.84%
Oper. Margin
-4.34%
Profit Margin
-7.41%
SMA20
-16.48%
SMA50
-15.54%
SMA200
-28.57%
Trades
Shs Outstand
40.73M
Shs Float
40.24M
52W High
16.42 -52.41%
52W Low
7.81 0.06%
Volatility
9.24% 5.39%
ATR (14)
0.65
RSI (14)
34.80
Beta
0.67
Rel Volume
4.66
Avg Volume
407.54K
Volume
1,673,771
Perf Week
-10.69%
Perf Month
-14.78%
Perf Quarter
-24.27%
Perf Half Y
-33.03%
Perf YTD
-48.45%
Perf Year
-47.76%
Perf 3Y
-26.48%
Perf 5Y
-76.81%
Perf 10Y
-78.92%
Prev Close
7.87
Price
7.82
Change %
-0.70%
Analysts 11 incl. previous ratings
Rating Distribution 7 Buy · 4 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Jan 27, 2026 Initiated T TD Cowen
Hold $14 +79.1% Oct 28, 2025 Resumed S Stifel
Buy $22 +181.5% Jan 22, 2025 Initiated C
Buy $24 +207.1% Nov 08, 2024 Upgrade S Stifel
Hold → Buy $18 → $24 +207.1% May 08, 2024 Upgrade R
Neutral → Buy $15 → $20 +155.9% Oct 20, 2023 Initiated R
Neutral $12 +53.6% Sep 12, 2023 Downgrade S Stifel
Buy → Hold Sep 12, 2023 Downgrade B
Buy → Neutral Jul 19, 2023 Resumed B
Buy $27 +245.5% Mar 04, 2022 Upgrade S Stifel
Hold → Buy $41 → $45 +475.8% Oct 20, 2020 Initiated S Stifel
Hold $39 +399.0% Oct 29, 2019 Downgrade C
Overweight → Neutral $71 → $48 +514.2% Jun 01, 2018 Initiated C
Overweight Jun 21, 2017 Initiated B
Buy $52 +565.4% Jun 14, 2017 Initiated L
Buy $53.25 +581.4% May 23, 2017 Initiated S
Buy $49 +527.0% Jul 10, 2015 Initiated S
Buy May 09, 2013 Downgrade M Mizuho
Buy → Neutral $45 → $28 +258.3% Jan 08, 2013 Reiterated M Mizuho
Buy $47 → $45 +475.8% Jun 21, 2010 Initiated B
Outperform $45 +475.8%
Today 09:50AM
07:16AM
06:00AM
Nov-02-26 04:03PM
Oct-23-26 04:00PM
03:12PM
Loading…
Oct-13-26 03:12PM
Oct-12-26 12:55PM
Aug-05-26 05:03PM
07:14AM
07:00AM
Jul-29-26 11:00AM
Jul-21-26 09:00AM
Jul-20-26 07:00AM
Jul-15-26 07:00AM
Jun-05-26 03:47PM
07:06PM
Loading…
May-29-26 07:06PM
May-18-26 07:00AM
May-06-26 07:00AM
May-05-26 03:47PM
07:28AM
07:00AM
Apr-21-26 07:00AM
Apr-09-26 07:00AM
Mar-11-26 12:31PM
Mar-02-26 10:22AM
Feb-24-26 04:02PM
12:49PM
09:40AM
07:52AM
(Associated Press Finance)
07:00AM
06:53PM
Loading…
Feb-20-26 06:53PM
Feb-19-26 05:20PM
Feb-10-26 07:00AM
Feb-03-26 07:00AM
Jan-09-26 07:00AM
Nov-04-25 04:08PM
08:20AM
07:19AM
(Associated Press Finance)
07:00AM
Nov-03-25 07:56AM
Oct-31-25 05:42PM
Oct-15-25 07:00AM
Oct-14-25 07:00AM
Oct-07-25 11:40AM
Oct-03-25 06:49PM
Oct-02-25 10:13AM
Sep-15-25 09:12AM
Aug-13-25 12:08PM
Aug-07-25 11:40AM
Aug-05-25 08:25AM
07:25AM
(Associated Press Finance)
07:00AM
Aug-04-25 10:00AM
07:40AM
Jul-16-25 07:00AM
Jul-15-25 07:00AM
Jun-17-25 07:00AM
May-07-25 03:09AM
12:09AM
(Thomson Reuters StreetEvents)
May-06-25 08:35AM
07:36AM
(Associated Press Finance)
07:00AM
May-05-25 10:08AM
Apr-22-25 05:15PM
Apr-18-25 02:06PM
Apr-15-25 08:00AM
Mar-19-25 08:00AM
Mar-12-25 08:00AM
Mar-07-25 07:51AM
Mar-03-25 07:00AM
Feb-26-25 02:18AM
(Thomson Reuters StreetEvents)
02:07AM
Feb-25-25 08:35AM
07:41AM
(Associated Press Finance)
07:00AM
01:44AM
Feb-17-25 07:05AM
Jan-28-25 07:00AM
Nov-12-24 07:05AM
Nov-08-24 07:32AM
02:14AM
Nov-07-24 08:25AM
07:23AM
(Associated Press Finance)
07:05AM
07:05AM
Nov-06-24 07:30AM
Oct-21-24 07:00AM
Oct-10-24 07:00AM
Oct-09-24 12:34PM
Sep-27-24 05:45AM
Sep-23-24 07:00AM
Sep-13-24 05:45AM
Aug-30-24 10:22AM
Aug-15-24 05:52PM
Aug-07-24 06:09AM
(Thomson Reuters StreetEvents)
Aug-06-24 08:15AM
07:17AM
(Associated Press Finance)
07:03AM
Jul-17-24 07:00AM
Jul-16-24 07:00AM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Fisher Patrick President, Global Limb Recon Nov 02 '26 Sale 9.07 150 1,360 50,769 Nov 04 04:04 PM Fisher Patrick President, Global Limb Recon Oct 01 '26 Sale 9.44 150 1,416 50,919 Oct 05 04:20 PM Fisher Patrick President, Global Limb Recon Sep 01 '26 Sale 9.39 150 1,408 51,069 Sep 03 04:41 PM PATRICK FISHER Officer Sep 01 '26 Proposed Sale 9.39 450 4,226 Sep 01 04:40 PM Fisher Patrick President, Global Limb Recon Aug 18 '26 Sale 10.09 1,295 13,067 51,219 Aug 20 05:03 PM McPherron Aviva Pres, Global Ops & Qual Jun 18 '26 Sale 9.38 3,670 34,425 66,330 Jun 22 04:14 PM HENNEMAN JOHN B III Director May 07 '26 Buy 12.26 5,000 61,295 90,809 May 08 04:52 PM Engine Capital Management, LP 10% Owner May 05 '26 Buy 11.99 112,950 1,354,587 3,783,131 May 07 06:15 PM Engine Capital Management, LP 10% Owner May 06 '26 Buy 12.23 41,946 512,916 3,821,285 May 07 06:15 PM Engine Capital Management, LP 10% Owner May 07 '26 Buy 12.18 30,000 365,425 3,848,573 May 07 06:15 PM Cedron Jorge Andres CLO Apr 16 '26 Sale 12.82 3,743 47,985 59,006 Apr 20 04:11 PM Vitale Lucas CP&BOO Mar 17 '26 Sale 11.92 4,269 50,886 160,449 Mar 19 04:31 PM CAPPS VICKIE L Director Mar 09 '26 Buy 12.48 2,500 31,200 25,085 Mar 10 04:13 PM CAPPS VICKIE L Director Mar 10 '26 Buy 12.45 2,500 31,124 27,585 Mar 10 04:13 PM Andrews Julie CFO Mar 04 '26 Sale 12.92 2,425 31,322 91,109 Mar 06 04:20 PM Andrews Julie CFO Mar 05 '26 Sale 12.55 2,363 29,658 88,746 Mar 06 04:20 PM Vitale Lucas CP&BOO Mar 04 '26 Sale 12.92 1,171 15,125 165,859 Mar 06 04:19 PM Vitale Lucas CP&BOO Mar 05 '26 Sale 12.55 1,141 14,320 164,718 Mar 06 04:19 PM Calafiore Massimo President & CEO Mar 04 '26 Sale 12.92 6,189 79,939 326,167 Mar 06 04:17 PM Calafiore Massimo President & CEO Mar 05 '26 Sale 12.55 6,031 75,694 320,136 Mar 06 04:17 PM Fisher Patrick President, Global Limb Recon Mar 04 '26 Sale 12.92 778 10,049 51,391 Mar 06 04:17 PM Fisher Patrick President, Global Limb Recon Mar 05 '26 Sale 12.55 758 9,514 50,633 Mar 06 04:17 PM McPherron Aviva Pres, Global Ops & Qual Mar 04 '26 Sale 12.92 1,296 16,740 69,116 Mar 06 04:16 PM McPherron Aviva Pres, Global Ops & Qual Mar 05 '26 Sale 12.55 1,263 15,852 67,853 Mar 06 04:16 PM REINHARDT MAX President, Global Spine Mar 04 '26 Sale 12.92 1,080 13,950 26,401 Mar 06 04:14 PM REINHARDT MAX President, Global Spine Mar 05 '26 Sale 12.55 1,053 13,216 25,348 Mar 06 04:14 PM Cedron Jorge Andres CLO Mar 04 '26 Sale 12.92 1,405 18,147 64,119 Mar 06 04:14 PM Cedron Jorge Andres CLO Mar 05 '26 Sale 12.55 1,370 17,195 62,749 Mar 06 04:14 PM Engine Capital Management, LP 10% Owner Feb 24 '26 Buy 12.55 124,797 1,565,641 3,663,133 Feb 26 05:48 PM Engine Capital Management, LP 10% Owner Feb 25 '26 Buy 12.96 13,061 169,315 3,673,092 Feb 26 05:48 PM Andrews Julie CFO Jan 16 '26 Sale 14.38 4,873 70,074 58,039 Jan 21 04:09 PM Calafiore Massimo President & CEO Jan 09 '26 Sale 15.82 9,600 151,906 227,034 Jan 13 05:46 PM Calafiore Massimo President & CEO Jan 12 '26 Sale 15.21 9,797 149,050 217,237 Jan 13 05:46 PM
Orthofix Medical, Inc. develops and markets medical devices and biologic solutions for spine and orthopedic applications. The company operates through two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers two primary product categories: Bone Growth Therapies and Spinal Implants, Biologics, and Enabling Technologies. Bone Growth Therapies includes noninvasive stimulation devices used in spinal fusion and fracture-healing applications. Spinal Implants, Biologics, and Enabling Technologies includes a broad portfolio of spine fixation and motion-preservation products, biologic solutions, and image-guided surgical technologies used in spine procedures. The Global Limb Reconstruction segment provides products and solutions for limb reconstruction, deformity correction, fracture management, and other orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.
President Mr. Massimo Calafiore
Chief Financial Officer Ms. Julie B. Andrews
President of Global Operations & Quality Ms. Aviva McPherron
Chief Legal Officer & Corporate Secretary Mr. J. Andres Cedron
President of Global Biologics & Limb Reconstruction Mr. Patrick Fisher
O